As Volpi celebrates its 70th anniversary, we stand at the precipice of a new diagnostics era that promises unprecedented accuracy, reliability, and cost-efficiency. Over the past seven decades, Volpi has established itself as a powerhouse in the industry, offering an integrated suite of services that has transformed the landscape of diagnostic instruments. Looking forward to the next decade, we are committed to upholding our tradition of excellence, fulfilling our promise of value to customers, and expanding the limits of the possible.
The Future is Connected and Data-Driven
Volpi is at the forefront of transforming diagnostic approaches with connected prototypes that facilitate real-time feedback for ultra-responsive project steering. This leading-edge method enables us not just to keep pace with industry trends but to define them. We leverage the data generated by prototypes to continuously refine performance, fostering a seamless feedback loop between Volpi and our clients.

Consolidation and De-Risking: A Strategic Imperative
In a world where leaders are accelerating their efforts to consolidate the supply chain and de-risk production, Volpi stands uniquely positioned to meet these needs with our dual manufacturing locations. Our Dietikon facility, situated in the heart of the traditional Swiss watchmaking industry near Zurich, and our Auburn site, located within the high-tech optics cluster in upstate New York, both feature state-of-the-art ISO 13485-certified spaces. These strategic locations serve as strongholds of quality and dependability amidst the increasingly volatile international trade environment.
Our Swiss and American facilities are well-prepared to accommodate the rising demand from industry players seeking to relocate their production to more secure regions. With expanded capabilities, including automated processes and streamlined logistics, we are equipped to address the growing preference for onshoring production. This strategic foresight, coupled with our expertise, ensures that Volpi remains at the forefront of the industry, ready to address the next decade’s challenges with efficiency and expertise.
By continuing to invest in our facilities, we reinforce our commitment to excellence, operational efficiency, and security, offering our partners the stability and confidence they require in a shifting global market. Volpi’s presence in these key geographical locations positions us as a service provider and a vital partner in pursuing a more resilient and responsive supply chain.

Delivering Customer Value Through Speed and Precision
Our commitment to customer value is unwavering. With faster time-to-market and more accurate decision-making, we help our customers de-risk their ventures. We will further elevate our capabilities and offer comprehensive assay development support as we expand initiatives to integrate AI for cost-efficient quality control processes. This all-encompassing approach, from development to assay testing, accelerates time to market and cements our role as full-service providers.

Investing in the Future: Infrastructure and Talent
Volpi is actively building an infrastructure and staffing model to enhance our software and algorithm development capabilities, ensuring we stay at the forefront of the field. Volpi is preparing to offer state-of-the-art solutions as healthcare moves toward greater reliance on AI and algorithm-supported diagnostics and treatment. We are drawing in global talent to join us in this significant shift, heralding a new chapter in patient care—from light to insights, powered by advanced computer models and algorithms.

Addressing Industry-Relevant Trends
Volpi doesn’t just respond to industry trends; we actively shape them. Our operations are streamlined for quicker market entry and expedited development. We lead the way in nearshoring and de-risking and are instrumental in supply chain consolidation. Our technological advancements are equally notable, with lab-in-a-system POC instruments that match core-lab performance, workflows tailored for point-of-need and CLIA-waived instruments, and ultra-high-sensitivity applications, including liquid biopsy and rapid AST.
A Commitment to Cost-Effective Care with Better Outcomes
The key industry priority of delivering cost-effective care with better outcomes is at the heart of Volpi’s mission. As we celebrate our 70th anniversary, we look back at our achievements and look forward to the opportunities and challenges that lie ahead. With a clear vision for the next ten years, Volpi is ready to lead the charge in diagnostic innovation, ensuring that we continue to provide value to our customers and contribute to advancing global healthcare.
As we embark on this journey, we invite you to join us in celebrating our past and shaping our future. Here’s to the next decade of excellence with Volpi—where every breakthrough brings us closer to a healthier world.
Simon Langhart
Head of Sales and Marketing